EP Patent

EP1534363A2 — Uveoscleral drainage device

Assigned to Yale University · Expires 2005-06-01 · 21y expired

What this patent protects

An ophthalmic shunt (10) implantable in an eye having an elongate body (20) and a conduit (40) for conducting aqueous humor from an anterior chamber of the eye to the suprachoroidal space of the eye. The elongate body has a forward end (22) and an insertion head (26) that extends…

USPTO Abstract

An ophthalmic shunt (10) implantable in an eye having an elongate body (20) and a conduit (40) for conducting aqueous humor from an anterior chamber of the eye to the suprachoroidal space of the eye. The elongate body has a forward end (22) and an insertion head (26) that extends from the forward end. The insertion head defines a shearing edge (28) suitable for cutting eye tissue engage thereby. The forward end and the insertion head of the body define a shoulder surface (30). The conduit has a first end defined on a portion of a top surface of the insertion head. The conduit also extends through the body from the forward end to a back end thereof. The first end of the conduit is spaced from the shearing edge and, in one example, from the shoulder of the body.

Drugs covered by this patent

Patent Metadata

Patent number
EP1534363A2
Jurisdiction
EP
Classification
Expires
2005-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Yale University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.